Comments on “Immune Checkpoint Inhibitor‐Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: A Systematic Review and meta‐Analysis” | Synapse
Comments on “Immune Checkpoint Inhibitor‐Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: A Systematic Review and meta‐Analysis”
Puntos clave
This commentary addresses the findings and implications of adjuvant treatment versus surveillance for hepatocellular carcinoma.
Systematic review of existing literature on immune checkpoint inhibitors and surveillance practices.
Analysis of treatment outcomes and patient management strategies in hepatocellular carcinoma cases.
No datasets were generated or analyzed, focusing primarily on existing findings and interpretations.
Resumen
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.